Literature DB >> 34527528

Effects of exercise training on heart rate variability in children and adolescents with pulmonary arterial hypertension: a pilot study.

Jannos Siaplaouras1, Marc Frerix2, Anita Apitz1, David Zöller3, Christian Apitz1,3.   

Abstract

BACKGROUND: Pulmonary arterial hypertension (PAH) is often associated with cardiac autonomic dysfunction, and heart rate variability (HRV) as marker of cardiac autonomic function is even related to disease severity. Knowledge about the effects of physical activity on HRV is limited in these patients. We aimed to assess whether HRV parameters can be influenced by a supervised exercise training program and whether respective changes are related to levels of activity.
METHODS: Six children and adolescents with moderate PAH (3 female, mean age 15.0±4.4 years; mean pulmonary to systemic arterial pressure ratio 0.5±0.2) performed supervised endurance and resistance training for 16 weeks. PAH-specific targeted medication remained unchanged during the study period. HRV was assessed before training and after 16 weeks of training by the use of ECG Move accelerometers. HRV indices included: standard deviation of normal-to-normal (NN) intervals (SDNN), square root of the mean of the sum of the squares of differences between successive NN-intervals (RMSSD), proportion of the number of pairs of successive normal-to-normal intervals that differ by more than 50 ms divided by total number of normal-to-normal interval (pNN50), and the Baevsky stress index (BSI) calculated by the histogram method.
RESULTS: Before and after the training program, SDNN, RMSSD and pNN50 correlated with the level of physical activity. Mean values of SDNN, RMSSD and pNN50 did not change significantly due to the training program. Notably, activity level depending SDNN increased markedly after the exercise program (during activity +12.4%, at rest +6.6% and reclining +8.1%, Hedge's g of 0.28, 0.14 and 0.27, respectively). BSI decreased during activity due to the training program reflecting a reduction of stress level (Hedge's g -0.87 indicating an effect of clinical relevance).
CONCLUSIONS: According to the experience of this pilot study a workout program of 16 weeks revealed an activity level dependent effect on parameters of autonomic cardiac function in children and adolescents with PAH. This mechanism might contribute to the positive effects of exercise training in patients with PAH. 2021 Cardiovascular Diagnosis and Therapy. All rights reserved.

Entities:  

Keywords:  Heart rate variability (HRV); congenital heart disease; exercise training; pulmonary hypertension; stress related cardiac autonomic regulation

Year:  2021        PMID: 34527528      PMCID: PMC8410481          DOI: 10.21037/cdt-20-263

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN: 2223-3652


  35 in total

Review 1.  Treatment of pulmonary arterial hypertension in children.

Authors:  Heiner Latus; Tammo Delhaas; Dietmar Schranz; Christian Apitz
Journal:  Nat Rev Cardiol       Date:  2015-02-03       Impact factor: 32.419

2.  Effects of exercise training in patients with idiopathic pulmonary arterial hypertension.

Authors:  F S de Man; M L Handoko; H Groepenhoff; A J van 't Hul; J Abbink; R J H Koppers; H P Grotjohan; J W R Twisk; H-J Bogaard; A Boonstra; P E Postmus; N Westerhof; W J van der Laarse; A Vonk-Noordegraaf
Journal:  Eur Respir J       Date:  2009-09       Impact factor: 16.671

Review 3.  The utility of low frequency heart rate variability as an index of sympathetic cardiac tone: a review with emphasis on a reanalysis of previous studies.

Authors:  Gustavo A Reyes del Paso; Wolf Langewitz; Lambertus J M Mulder; Arie van Roon; Stefan Duschek
Journal:  Psychophysiology       Date:  2013-02-27       Impact factor: 4.016

4.  Counting Steps: A New Way to Monitor Patients with Pulmonary Arterial Hypertension.

Authors:  Sameep Sehgal; Ananda Chowdhury; Fadi Rabih; Abhishek Gadre; Margaret M Park; Manshi Li; Xiaofeng Wang; Kristin B Highland
Journal:  Lung       Date:  2019-05-29       Impact factor: 2.584

5.  Outcome of pediatric patients with pulmonary arterial hypertension in the era of new medical therapies.

Authors:  Rosa Laura E van Loon; Marcus T R Roofthooft; Tammo Delhaas; Magdalena van Osch-Gevers; Arend D J ten Harkel; Jan L M Strengers; Ad Backx; Hans L Hillege; Rolf M F Berger
Journal:  Am J Cardiol       Date:  2010-07-01       Impact factor: 2.778

6.  Treatment and survival in children with pulmonary arterial hypertension: the UK Pulmonary Hypertension Service for Children 2001-2006.

Authors:  S G Haworth; A A Hislop
Journal:  Heart       Date:  2008-10-24       Impact factor: 5.994

7.  Long-term outcomes in children with pulmonary arterial hypertension treated with bosentan in real-world clinical settings.

Authors:  D Dunbar Ivy; Erika Berman Rosenzweig; Jean-Christophe Lemarié; Monika Brand; Daniel Rosenberg; Robyn J Barst
Journal:  Am J Cardiol       Date:  2010-11-01       Impact factor: 2.778

8.  Exercise training in pulmonary arterial hypertension associated with connective tissue diseases.

Authors:  Ekkehard Grünig; Felicitas Maier; Nicola Ehlken; Christine Fischer; Mona Lichtblau; Norbert Blank; Christoph Fiehn; Frank Stöckl; Felix Prange; Gerd Staehler; Frank Reichenberger; Henning Tiede; Michael Halank; Hans-Jürgen Seyfarth; Simone Wagner; Christian Nagel
Journal:  Arthritis Res Ther       Date:  2012-06-18       Impact factor: 5.156

9.  Reduced free-living activity levels in pulmonary arterial hypertension patients.

Authors:  Stephen J Halliday; Huang Shi; Evan L Brittain; Anna R Hemnes
Journal:  Pulm Circ       Date:  2018-11-13       Impact factor: 3.017

10.  Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial.

Authors:  Nicola Ehlken; Mona Lichtblau; Hans Klose; Johannes Weidenhammer; Christine Fischer; Robert Nechwatal; Sören Uiker; Michael Halank; Karen Olsson; Werner Seeger; Henning Gall; Stephan Rosenkranz; Heinrike Wilkens; Dirk Mertens; Hans-Jürgen Seyfarth; Christian Opitz; Silvia Ulrich; Benjamin Egenlauf; Ekkehard Grünig
Journal:  Eur Heart J       Date:  2015-07-31       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.